Brad R Henke

Title: The Innovations of Brad R Henke

Introduction

Brad R Henke is an accomplished inventor based in Cary, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent related to fused bicyclic alkylene linked imidodicarbonimidic diamides. His work focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Henke holds a patent for "Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy." This invention provides novel compounds, specifically N-[2-(indol-3-yl)alkylene]-linked imidodicarbonimidic diamides and N-[2-(pyrrolopyridin-3-yl)alkylene]-linked imidodicarbonimidic diamides. These compounds are believed to be selective for organic cation transporters and are useful in treating diseases associated with reduced activity of 5' adenosine monophosphate-activated protein kinase (AMPK).

Career Highlights

Henke's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Novatarg, Inc., where he continues to explore innovative solutions in drug development. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Throughout his career, Henke has collaborated with notable professionals in the field, including Kenneth Batchelor and Jeffery Edmond Cobb. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Brad R Henke is a notable inventor whose work in medicinal chemistry has led to significant advancements in therapeutic compounds. His patent on fused bicyclic alkylene linked imidodicarbonimidic diamides showcases his innovative approach to addressing medical challenges.